NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP 1 MG
NEOSTIGMINE METHYLSULFATE : 1 MG · DIN 01914588 · DAVID BULL LABORATORIES (PTY) LTD.
Health Canada status: CANCELLED POST MARKET
What is NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP?
NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP 1 MG contains NEOSTIGMINE METHYLSULFATE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 01914588, held by DAVID BULL LABORATORIES (PTY) LTD., supplied as LIQUID for INTRAMUSCULAR ; INTRAVENOUS ; SUBCUTANEOUS administration. Health Canada currently lists it as cancelled post market, status dated 10-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01914588 |
|---|---|
| Brand name | NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP |
| Generic / active ingredient | NEOSTIGMINE METHYLSULFATE : 1 MG |
| Manufacturer | DAVID BULL LABORATORIES (PTY) LTD. |
| Strength | 1 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS ; SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | N07AA01 NEOSTIGMINE |
| AHFS class | 12:04.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Sep-1996 |
| Original market date | 1991-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N07AA01 NEOSTIGMINE. 6 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEOSTIGMINE METHYLSULFATE INJECTION USP | 0.5 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02475480 |
| NEOSTIGMINE METHYLSULFATE INJECTION USP | 1 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02475499 |
| NEOSTIGMINE METHYLSULFATE INJECTION, USP | 0.5 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02537516 |
| NEOSTIGMINE OMEGA | 0.5 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02230593 |
| NEOSTIGMINE OMEGA | 1 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02230592 |
| NEOSTIGMINE OMEGA | 2.5 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02387166 |
| NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML USP | .5 MG | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 01904183 |
| NEOSTIGMINE METHYLSULFATE INJECTION | 0.5 MG | LIQUID | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02243104 |
| NEOSTIGMINE METHYLSULFATE INJECTION | 1 MG | LIQUID | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02243103 |
| NEOSTIGMINE METHYLSULFATE INJECTION SDZ | 0.5 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02385201 |
Who else supplies NEOSTIGMINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NEOSTIGMINE appears in 12 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.